{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T18:00:31Z","timestamp":1769968831569,"version":"3.49.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2012,3,8]],"date-time":"2012-03-08T00:00:00Z","timestamp":1331164800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1038\/hr.2012.29","type":"journal-article","created":{"date-parts":[[2012,3,8]],"date-time":"2012-03-08T11:45:20Z","timestamp":1331207120000},"page":"761-768","source":"Crossref","is-referenced-by-count":19,"title":["The effects of repeated delivery of angiotensin II AT1 receptor antisense on distinct vasoactive systems in Ren-2 transgenic rats: young vs. adult animals"],"prefix":"10.1038","volume":"35","author":[{"given":"Ivana","family":"Van\u011b\u010dkov\u00e1","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zdenka","family":"Dobe\u0161ov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaroslav","family":"Kune\u0161","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josef","family":"Zicha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,3,8]]},"reference":[{"key":"BFhr201229_CR1","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/344541a0","volume":"344","author":"JJ Mullins","year":"1990","unstructured":"Mullins JJ, Peters J, Ganten D . Fulminant hypertension in transgenic rats harbouring the mouse Ren-2 gene. Nature 1990; 344: 541\u2013544.","journal-title":"Nature"},{"key":"BFhr201229_CR2","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/0895-7061(95)00400-9","volume":"9","author":"M Langheinrich","year":"1996","unstructured":"Langheinrich M, Lee MA, Bohm M, Pinto YM, Ganten D, Paul M . The hypertensive Ren-2 transgenic rat TGR (mREN2)27 in hypertension research. Characteristics and functional aspects. Am J Hypertens 1996; 9: 506\u2013512.","journal-title":"Am J Hypertens"},{"key":"BFhr201229_CR3","first-page":"F731","volume":"266","author":"JE Springate","year":"1994","unstructured":"Springate JE, Feld LG, Ganten D . Renal function in hypertensive rats transgenic for mouse renin gene. Am J Physiol 1994; 266: F731\u2013F737.","journal-title":"Am J Physiol"},{"key":"BFhr201229_CR4","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1159\/000092981","volume":"29","author":"Z Huskova","year":"2006","unstructured":"Huskova Z, Kramer HJ, Thumova M, Vanourkova Z, Burgelova M, Teplan V, Maly J, Cervenka L . Effects of anesthesia on plasma and kidney II ANG levels in normotensive and ANG II-dependent hypertensive rats. Kidney Blood Press Res 2006; 29: 74\u201383.","journal-title":"Kidney Blood Press Res"},{"key":"BFhr201229_CR5","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1111\/j.1474-8673.1996.tb00414.x","volume":"16","author":"SM Arribas","year":"1996","unstructured":"Arribas SM, Alonso MJ, Marin J, Fernandes F, Llergo JL, Sanchez-Ferrer CF, Salaices M . Noradrenergic transmission in the tail artery of hypertensive rats transgenic for the mouse renin gene Ren-2. J Auton Pharmacol 1996; 16: 69\u201377.","journal-title":"J Auton Pharmacol"},{"key":"BFhr201229_CR6","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.vph.2009.06.001","volume":"51","author":"L Kopkan","year":"2009","unstructured":"Kopkan L, Huskova Z, Vanourkova Z, Thumova M, Skaroupkova P, Maly J, Kramer HJ, Dvorak P, Cervenka L . Reduction of oxidative stress does not attenuate the development of angiotensin II-dependent hypertension in Ren-2 transgenic rats. Vascul Pharmacol 2009; 51: 175\u2013181.","journal-title":"Vascul Pharmacol"},{"key":"BFhr201229_CR7","doi-asserted-by":"crossref","first-page":"17","DOI":"10.33549\/physiolres.930596","volume":"54","author":"I Vaneckova","year":"2005","unstructured":"Vaneckova I, Skaroupkova P, Dvorak P, Certikova CV, Tesar V, Bader M, Ganten D, Kramer HJ . Effects of sodium restriction and cyclooxygenase-2 inhibition on the course of hypertension, proteinuria and cardiac hypertrophy in Ren-2 transgenic rats. Physiol Res 2005; 54: 17\u201324.","journal-title":"Physiol Res"},{"key":"BFhr201229_CR8","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1159\/000084649","volume":"28","author":"I Vaneckova","year":"2005","unstructured":"Vaneckova I, Kramer HJ, Novotna J, Kazdova L, Opocensky M, Bader M, Ganten D, Cervenka L . Roles of nitric oxide and oxidative stress in the regulation of blood pressure and renal function in prehypertensive Ren-2 transgenic rats. Kidney Blood Press Res 2005; 28: 117\u2013126.","journal-title":"Kidney Blood Press Res"},{"key":"BFhr201229_CR9","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1042\/cs1020269","volume":"102","author":"J Kunes","year":"2002","unstructured":"Kunes J, Dobesova Z, Zicha J . Altered balance of main vasopressor and vasodepressor systems in rats with genetic hypertension and hypertriglyceridaemia. Clin Sci (Lond) 2002; 102: 269\u2013277.","journal-title":"Clin Sci (Lond)"},{"key":"BFhr201229_CR10","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1097\/00004872-200401000-00026","volume":"22","author":"O Pechanova","year":"2004","unstructured":"Pechanova O, Dobesova Z, Cejka J, Kunes J, Zicha J . Vasoactive systems in L-NAME hypertension: the role of inducible nitric oxide synthase. J Hypertens 2004; 22: 167\u2013173.","journal-title":"J Hypertens"},{"key":"BFhr201229_CR11","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1097\/00004872-200102000-00011","volume":"19","author":"J Zicha","year":"2001","unstructured":"Zicha J, Dobesova Z, Kunes J . Relative deficiency of nitric oxide-dependent vasodilation in salt-hypertensive Dahl rats: the possible role of superoxide anions. J Hypertens 2001; 19: 247\u2013254.","journal-title":"J Hypertens"},{"key":"BFhr201229_CR12","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.molmed.2005.03.008","volume":"11","author":"LG Melo","year":"2005","unstructured":"Melo LG, Pachori AS, Gnecchi M, Dzau VJ . Genetic therapies for cardiovascular diseases. Trends Mol Med 2005; 11: 240\u2013250.","journal-title":"Trends Mol Med"},{"key":"BFhr201229_CR13","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1097\/HJH.0b013e3280113950","volume":"25","author":"H Krum","year":"2007","unstructured":"Krum H, Gilbert RE . Novel therapies blocking the renin-angiotensin-aldosterone system in the management of hypertension and related disorders. J Hypertens 2007; 25: 25\u201335.","journal-title":"J Hypertens"},{"key":"BFhr201229_CR14","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1038\/sj.gt.3302838","volume":"13","author":"SD Li","year":"2006","unstructured":"Li SD, Huang L . Gene therapy progress and prospects: non-viral gene therapy by systemic delivery. Gene Therapy 2006; 13: 1313\u20131319.","journal-title":"Gene Therapy"},{"key":"BFhr201229_CR15","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.vph.2007.04.005","volume":"47","author":"I Vaneckova","year":"2007","unstructured":"Vaneckova I, Kopkan L, Huskova Z, Vanourkova Z, Schejbalova S, Cervenka L, Kramer HJ . AT1 receptor antisense therapy transiently lowers blood pressure in Ren-2 transgenic rats. Vasc Pharmacol 2007; 47: 63\u201367.","journal-title":"Vasc Pharmacol"},{"key":"BFhr201229_CR16","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1161\/01.HYP.37.2.376","volume":"37","author":"B Kimura","year":"2001","unstructured":"Kimura B, Mohuczy D, Tang X, Phillips MI . Attenuation of hypertension and heart hypertrophy by adeno-associated virus delivering angiotensinogen antisense. Hypertension 2001; 37: 376\u2013380.","journal-title":"Hypertension"},{"key":"BFhr201229_CR17","doi-asserted-by":"publisher","first-page":"9960","DOI":"10.1073\/pnas.93.18.9960","volume":"93","author":"SN Iyer","year":"1996","unstructured":"Iyer SN, Lu D, Katovich MJ, Raizada MK . Chronic control of high blood pressure in the spontaneously hypertensive rat by delivery of angiotensin type 1 receptor antisense. Proc Natl Acad Sci USA 1996; 93: 9960\u20139965.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFhr201229_CR18","first-page":"H1260","volume":"277","author":"MJ Katovich","year":"1999","unstructured":"Katovich MJ, Gelband CH, Reaves P, Wang HW, Raizada MK . Reversal of hypertension by angiotensin II type 1 receptor antisense gene therapy in the adult SHR. Am J Physiol 1999; 277: H1260\u2013H1264.","journal-title":"Am J Physiol"},{"key":"BFhr201229_CR19","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1161\/01.HYP.0000017827.63253.16","volume":"39","author":"AS Pachori","year":"2002","unstructured":"Pachori AS, Numan MT, Ferrario CM, Diz DM, Raizada MK, Katovich MJ . Blood pressure-independent attenuation of cardiac hypertrophy by AT(1)R-AS gene therapy. Hypertension 2002; 39: 969\u2013975.","journal-title":"Hypertension"},{"key":"BFhr201229_CR20","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1161\/01.HYP.31.6.1317","volume":"31","author":"JF Peng","year":"1998","unstructured":"Peng JF, Kimura B, Fregly MJ, Phillips MI . Reduction of cold-induced hypertension by antisense oligodeoxynucleotides to angiotensinogen mRNA and AT1-receptor mRNA in brain and blood. Hypertension 1998; 31: 1317\u20131323.","journal-title":"Hypertension"},{"key":"BFhr201229_CR21","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1042\/cs0890177","volume":"89","author":"N Minami","year":"1995","unstructured":"Minami N, Imai Y, Hashimoto J, Abe K . Contribution of vascular nitric oxide to basal blood pressure in conscious spontaneously hypertensive rats and normotensive wistar kyoto rats. Clin Sci (Lond) 1995; 89: 177\u2013182.","journal-title":"Clin Sci (Lond)"},{"key":"BFhr201229_CR22","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1152\/physrev.1999.79.4.1227","volume":"79","author":"J Zicha","year":"1999","unstructured":"Zicha J, Kunes J . Ontogenetic aspects of hypertension development: analysis in the rat. Physiol Rev 1999; 79: 1227\u20131282.","journal-title":"Physiol Rev"},{"key":"BFhr201229_CR23","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1097\/00004872-200205000-00030","volume":"20","author":"Z Dobesova","year":"2002","unstructured":"Dobesova Z, Kunes J, Zicha J . The altered balance between sympathetic nervous system and nitric oxide in salt hypertensive dahl rats: ontogenetic and F2 hybrid studies. J Hypertens 2002; 20: 945\u2013955.","journal-title":"J Hypertens"},{"key":"BFhr201229_CR24","first-page":"837","volume":"59","author":"J Zicha","year":"2010","unstructured":"Zicha J, Vaneckova I, Kunes J . Systems analysis in hypertension: complementary role of physiologists and geneticists. Physiol Res 2010; 59: 837\u2013839.","journal-title":"Physiol Res"},{"key":"BFhr201229_CR25","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/S0008-6363(02)00400-5","volume":"55","author":"GP Rossi","year":"2002","unstructured":"Rossi GP, Cavallin M, Belloni AS, Mazzocchi G, Nussdorfer GG, Pessina AC, Sartore S . Aortic smooth muscle cell phenotypic modulation and fibrillar collagen deposition in angiotensin II-dependent hypertension. Cardiovasc Res 2002; 55: 178\u2013189.","journal-title":"Cardiovasc Res"},{"key":"BFhr201229_CR26","doi-asserted-by":"publisher","first-page":"56S","DOI":"10.1016\/S0895-7061(97)00076-9","volume":"10","author":"R Gyurko","year":"1997","unstructured":"Gyurko R, Tran D, Phillips MI . Time course of inhibition of hypertension by antisense oligonucleotides targeted to AT1 angiotensin receptor mRNA in spontaneously hypertensive rats. Am J Hypertens 1997; 10: 56S\u201362S.","journal-title":"Am J Hypertens"},{"key":"BFhr201229_CR27","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1161\/01.HYP.37.2.371","volume":"37","author":"S Kagiyama","year":"2001","unstructured":"Kagiyama S, Varela A, Phillips MI, Galli SM . Antisense inhibition of brain renin-angiotensin system decreased blood pressure in chronic 2-kidney, 1 clip hypertensive rats. Hypertension 2001; 37: 371\u2013375.","journal-title":"Hypertension"},{"key":"BFhr201229_CR28","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1159\/000098869","volume":"30","author":"I Vaneckova","year":"2007","unstructured":"Vaneckova I, Kopkan L, Huskova Z, Vanourkova Z, Schejbalova S, Cervenka L, Kramer HJ . Long-term prevention of hypertension and end-organ damage in Ren-2 transgenic rats is achieved only with persistent but not transient AT1 receptor blockade. Kidney Blood Press Res 2007; 30: 38\u201344.","journal-title":"Kidney Blood Press Res"},{"key":"BFhr201229_CR29","doi-asserted-by":"publisher","first-page":"F758","DOI":"10.1152\/ajprenal.00259.2010","volume":"299","author":"D Rakusan","year":"2010","unstructured":"Rakusan D, Kujal P, Kramer HJ, Huskova Z, Vanourkova Z, Vernerova Z, Mrazova I, Thumova M, Cervenka L, Vaneckova I . Persistent antihypertensive effect of aliskiren is accompanied by reduced proteinuria and normalization of glomerular area in Ren-2 transgenic rats. Am J Physiol Renal Physiol 2010; 299: F758\u2013F766.","journal-title":"Am J Physiol Renal Physiol"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/hr201229.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/hr201229","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/hr201229.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,20]],"date-time":"2023-06-20T23:44:48Z","timestamp":1687304688000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/hr201229"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,8]]},"references-count":29,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["BFhr201229"],"URL":"https:\/\/doi.org\/10.1038\/hr.2012.29","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,8]]}}}